Prescription Drug Misuse (R03)

The summary for the Prescription Drug Misuse (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Prescription Drug Misuse (R03): -Purpose. The National Institute on Drug Abuse and the National Institute of Mental Health invites research applications to reduce prescription drug misuse while supporting the appropriate medical use of therapeutic agents that carry an abuse liability. A range of research is being solicited to combat prescription drug misuse from epidemiologic research specifying the extent and nature of the problem (including physical and mental health and social consequences) as it relates to each specific drug and identifying determinants and trajectories of use. Basic science applications to determine mechanisms of action at the cellular level and possible mechanisms or medications to block or lessen the abuse potential are encouraged, as are health services applications with the goal of discovering effective clinical practices that identify those at risk and designing and disseminating prevention and treatment interventions. -The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. -Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-127, that encourages applications under the R01mechanism and PA-08-128 that encourages applications under the R21 mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Federal Grant Title: Prescription Drug Misuse (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-08-129
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: May 07, 2011
Original Application Deadline: May 07, 2011
Posted Date: Apr 03, 2008
Creation Date: Dec 05, 2008
Archive Date: Jun 07, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith-based or Community-based Organizations Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non-domestic (non-U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exp...
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Al...
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Li...
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Inco...
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Research on biopsychosocial factors of social connectedness and isolation on health, wellb...
Research on biopsychosocial factors of social connectedness and isolation on health, wellb...
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not All...
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
Patient Activation for Self-Management of Chronic Conditions (R21 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com